awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48263840-3F6903B8-C564-4FBB-BE89-DE7C2BC3F7D1
Q48263840-3F6903B8-C564-4FBB-BE89-DE7C2BC3F7D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48263840-3F6903B8-C564-4FBB-BE89-DE7C2BC3F7D1
Ipragliflozin and sodium glucose transporter 2 inhibitors to reduce liver fat: will the prize we sought be won?
P2860
Q48263840-3F6903B8-C564-4FBB-BE89-DE7C2BC3F7D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48263840-3F6903B8-C564-4FBB-BE89-DE7C2BC3F7D1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
82b6647f8d347546e90738905c05581e86f27792
P2860
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.